You are here
Nobivac® Myxo-RHD PLUS, lyophilisate and solvent for suspension for injection for rabbits
Nobivac Myxo-RHD PLUS is a live recombinant vector vaccine for rabbits indicated to reduce mortality and clinical signs of myxomatosis and rabbit haemorrhagic disease (RHD) caused by both classic (RHD1) and variant strains (RHD2)
Presentation
Lyophilisate and solvent for suspension for injection
Lyophilisate: off-white or cream-coloured pellet
Solvent: clear colourless solution
Active ingredients
Each dose (0.2 ml or 0.5 ml) of reconstituted vaccine contains:
Live myxoma vectored RHD virus strain 009: 103.0 - 105.8 FFU*
Live myxoma vectored RHD virus strain MK1899: 103.0 - 105.8 FFU*
*Focus Forming Units
Target species
Rabbits
Indications for use
For the active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and rabbit haemorrhagic disease (RHD) caused by classical RHD virus (RHDV-1) and RHD type 2 virus (RHDV-2).
Packaging
Plastic box with 5 x 1 dose vial of vaccine and 5 vials containing 0.5 ml of solvent.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: June 2024